Mizuho Securities USA LLC Buys 10,757 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mizuho Securities USA LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 46.8% in the 4th quarter, HoldingsChannel reports. The firm owned 33,758 shares of the medical equipment provider’s stock after purchasing an additional 10,757 shares during the period. Mizuho Securities USA LLC’s holdings in Intuitive Surgical were worth $17,620,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management lifted its holdings in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $492.49 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company’s 50-day moving average is $562.24 and its 200 day moving average is $531.34. The company has a market capitalization of $175.41 billion, a price-to-earnings ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

ISRG has been the subject of a number of recent research reports. Barclays boosted their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.